Skip to Main Content

Paper Details

A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Prostate
4
2021
Author NameAffiliation
Kristina M JordahlFred Hutchison Cancer Research Center
Travis GerkeMoffitt Cancer Center
Travis GerkeHarvard T.H. Chan School of Public Health
Travis GerkeMoffitt Cancer Center
Travis GerkeHarvard T.H. Chan School of Public Health
Kathryn L PenneyHarvard T.H. Chan School of Public Health
Kathryn L PenneyBrigham and Women's Hospital and Harvard Medical School
Matthew L FreedmanDana Farber Cancer Institute
Matthew L FreedmanDana Farber Cancer Institute
Mark M PomerantzDana Farber Cancer Institute
Mark M PomerantzDana Farber Cancer Institute
Timothy R RebbeckHarvard T.H. Chan School of Public Health
Curtis HuttenhowerHarvard T.H. Chan School of Public Health, Harvard University
Curtis HuttenhowerThe Broad Institute of MIT and Harvard
Rosalind A EelesThe Institute of Cancer Research
Rosalind A EelesThe Royal Marsden NHS Foundation Trust
Janet L StanfordFred Hutchison Cancer Research Center
Janet L StanfordFred Hutchison Cancer Research Center
Sonja I BerndtNational Cancer Institute
Lorelei A MucciHarvard T.H. Chan School of Public Health
  • 1 - 20

Datasets